CN108578560A - 一种治疗肝肾阴虚型自身免疫性肝炎的中药组合物及其制备方法 - Google Patents
一种治疗肝肾阴虚型自身免疫性肝炎的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN108578560A CN108578560A CN201810801025.XA CN201810801025A CN108578560A CN 108578560 A CN108578560 A CN 108578560A CN 201810801025 A CN201810801025 A CN 201810801025A CN 108578560 A CN108578560 A CN 108578560A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- medicine composition
- radix
- liver
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 64
- 239000000203 mixture Substances 0.000 title claims abstract description 28
- 208000006454 hepatitis Diseases 0.000 title claims abstract description 26
- 231100000283 hepatitis Toxicity 0.000 title claims abstract description 25
- 230000036039 immunity Effects 0.000 title claims abstract description 23
- 208000031971 Yin Deficiency Diseases 0.000 title claims abstract description 21
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 229940079593 drug Drugs 0.000 claims abstract description 18
- 239000000463 material Substances 0.000 claims abstract description 16
- 244000179560 Prunella vulgaris Species 0.000 claims abstract description 15
- 235000010674 Prunella vulgaris Nutrition 0.000 claims abstract description 15
- 241000096284 Gynochthodes officinalis Species 0.000 claims abstract description 14
- 241000830535 Ligustrum lucidum Species 0.000 claims abstract description 14
- 244000226566 Psoralea corylifolia Species 0.000 claims abstract description 14
- 241000405414 Rehmannia Species 0.000 claims abstract description 14
- 240000001341 Reynoutria japonica Species 0.000 claims abstract description 14
- 235000018167 Reynoutria japonica Nutrition 0.000 claims abstract description 14
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 14
- 210000000988 bone and bone Anatomy 0.000 claims abstract description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 15
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 12
- 235000019441 ethanol Nutrition 0.000 claims description 9
- 239000000284 extract Substances 0.000 claims description 9
- 239000000706 filtrate Substances 0.000 claims description 8
- 239000003208 petroleum Substances 0.000 claims description 8
- 238000001914 filtration Methods 0.000 claims description 7
- 238000000605 extraction Methods 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 6
- 238000010992 reflux Methods 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 239000012141 concentrate Substances 0.000 claims description 3
- 238000005238 degreasing Methods 0.000 claims description 3
- 239000012259 ether extract Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 210000003734 kidney Anatomy 0.000 abstract description 30
- 210000004185 liver Anatomy 0.000 abstract description 29
- 239000008280 blood Substances 0.000 abstract description 15
- 210000004369 blood Anatomy 0.000 abstract description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 7
- 201000010099 disease Diseases 0.000 abstract description 6
- 230000000694 effects Effects 0.000 abstract description 6
- 230000001225 therapeutic effect Effects 0.000 abstract description 5
- 230000017531 blood circulation Effects 0.000 abstract description 4
- 230000001737 promoting effect Effects 0.000 abstract description 4
- 241000721047 Danaus plexippus Species 0.000 abstract description 3
- 230000004069 differentiation Effects 0.000 abstract description 3
- 208000002193 Pain Diseases 0.000 description 11
- 208000024891 symptom Diseases 0.000 description 11
- 235000009508 confectionery Nutrition 0.000 description 9
- 208000002173 dizziness Diseases 0.000 description 8
- 239000000796 flavoring agent Substances 0.000 description 8
- 235000019634 flavors Nutrition 0.000 description 8
- 210000004072 lung Anatomy 0.000 description 7
- 230000007812 deficiency Effects 0.000 description 6
- 230000003908 liver function Effects 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 5
- 238000003745 diagnosis Methods 0.000 description 5
- 208000025865 Ulcer Diseases 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 3
- 206010046788 Uterine haemorrhage Diseases 0.000 description 3
- 210000003127 knee Anatomy 0.000 description 3
- 201000007227 lymph node tuberculosis Diseases 0.000 description 3
- 231100000862 numbness Toxicity 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 206010003827 Autoimmune hepatitis Diseases 0.000 description 2
- 208000008967 Enuresis Diseases 0.000 description 2
- 101710173228 Glutathione hydrolase proenzyme Proteins 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 208000037093 Menstruation Disturbances Diseases 0.000 description 2
- 206010027339 Menstruation irregular Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000007717 exclusion Effects 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 208000019423 liver disease Diseases 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000007958 sleep Effects 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010000242 Abortion threatened Diseases 0.000 description 1
- 206010049865 Achromotrichia acquired Diseases 0.000 description 1
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 1
- 108010082126 Alanine transaminase Proteins 0.000 description 1
- 241000213006 Angelica dahurica Species 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 241000522254 Cassia Species 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000218176 Corydalis Species 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 101710107035 Gamma-glutamyltranspeptidase Proteins 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019663 Hepatic failure Diseases 0.000 description 1
- 206010061998 Hepatic lesion Diseases 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 208000019758 Hypergammaglobulinemia Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241000123069 Ocyurus chrysurus Species 0.000 description 1
- 240000005001 Paeonia suffruticosa Species 0.000 description 1
- 235000003889 Paeonia suffruticosa Nutrition 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 244000197580 Poria cocos Species 0.000 description 1
- 235000008599 Poria cocos Nutrition 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 208000037656 Respiratory Sounds Diseases 0.000 description 1
- 244000153955 Reynoutria sachalinensis Species 0.000 description 1
- 235000003202 Reynoutria sachalinensis Nutrition 0.000 description 1
- 241000593989 Scardinius erythrophthalmus Species 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 208000005985 Threatened Abortion Diseases 0.000 description 1
- 206010043866 Tinea capitis Diseases 0.000 description 1
- 238000008050 Total Bilirubin Reagent Methods 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 230000006472 autoimmune response Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000019771 cognition Effects 0.000 description 1
- 238000000205 computational method Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 102000006640 gamma-Glutamyltransferase Human genes 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- WGXUDTHMEITUBO-YFKPBYRVSA-N glutaurine Chemical compound OC(=O)[C@@H](N)CCC(=O)NCCS(O)(=O)=O WGXUDTHMEITUBO-YFKPBYRVSA-N 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- 230000002962 histologic effect Effects 0.000 description 1
- 208000006278 hypochromic anemia Diseases 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 208000007903 liver failure Diseases 0.000 description 1
- 231100000835 liver failure Toxicity 0.000 description 1
- 208000018191 liver inflammation Diseases 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 238000013160 medical therapy Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000010341 ping gan Substances 0.000 description 1
- 210000004180 plasmocyte Anatomy 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 229940037128 systemic glucocorticoids Drugs 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 208000009189 tinea favosa Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 102000014898 transaminase activity proteins Human genes 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/487—Psoralea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/536—Prunella or Brunella (selfheal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/58—Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/638—Ligustrum, e.g. Chinese privet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/69—Polygalaceae (Milkwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/746—Morinda
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8964—Anemarrhena
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/35—Extraction with lipophilic solvents, e.g. Hexane or petrol ether
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Insects & Arthropods (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗肝肾阴虚型自身免疫性肝炎的中药组合物及其制备方法,该中药组合物包括以下重量计的原料药物:当归10‑16g、何首乌15‑20g、知母10‑12g、川楝子10‑16g、桑寄生5‑10g、女贞子15‑20g、远志5‑10g、夏枯草5‑10g、熟地黄10‑16g、补骨脂15‑18g、巴戟天12‑15g、露蜂房12‑15g、煅龙骨10‑12g、山茱萸4‑8g、甘草15‑20g。本发明在中医辨证与辨病论治理论指导下,按君臣佐使原则进行遣药组方,诸药合用,以养血柔肝,滋阴补肾,散结通络为主,兼具活血化瘀、清热解毒、祛风除湿之功效,主要针对肝肾阴虚型自身免疫性肝炎,对其它证型的自身免疫性肝炎也有一定的治疗效果。
Description
技术领域
本发明涉及一种治疗肝肾阴虚型自身免疫性肝炎的中药组合物及其制备方法,属于中药技术领域。
背景技术
自身免疫性肝炎是由自身免疫反应介导的慢性进行性肝脏炎症性疾病,其临床特征为不同程度的血清转氨酶升高、高γ-球蛋白血症、自身抗体阳性,组织学特征为以淋巴细胞、浆细胞浸润为主的界面性肝炎,严重病例可快速进展为肝硬化和肝衰竭。该病在世界范围内均有发生,在欧美国家发病率相对较高,在我国其确切发病率和患病率尚不清楚,但国内文献报道的病例数呈明显上升趋势。现代医学治疗主要以糖皮质激素等免疫抑制剂为主,减轻肝脏的自身弥漫异性炎症反应,同时采用保肝、退黄、降酶等药物治疗,但其弊端却逐渐显现。中药治疗自身免疫性肝炎以其特色被现代医者所接纳和推广。中医药诊治肝病历史悠久,早在中国汉代的《黄帝内经》上便有“诸风掉眩,皆属于肝”的论述,在治疗上提出:“肝主春,足厥阴,少阳主治,其日甲乙;肝苦急,急食甘以缓之”、“急食辛以散之,用辛补之,酸泻之”。现代医者在此基础上多有发挥,不同的医生对自身免疫性肝炎证型有其自身的看法,基本的认知是将自身免疫性肝炎分为:肝郁脾虚型、湿热中阻型、瘀血阻络型和肝肾阴虚型。中医治疗主要采用辨证施治的手段治疗自身免疫性肝炎,本发明主要针对肝肾阴虚型自身免疫性肝炎的治疗。
发明内容
针对现有技术的不足,本发明的目的是提供一种治疗肝肾阴虚型自身免疫性肝炎的中药组合物及其制备方法,能够有效治疗肝肾阴虚型自身免疫性肝炎。
为了实现上述目的,本发明的技术方案是:
一种治疗肝肾阴虚型自身免疫性肝炎的中药组合物,包括以下重量计的原料药物:当归10-16g、何首乌15-20g、知母10-12g、川楝子10-16g、桑寄生5-10g、女贞子15-20g、远志5-10g、夏枯草5-10g、熟地黄10-16g、补骨脂15-18g、巴戟天12-15g、露蜂房12-15g、煅龙骨10-12g、山茱萸4-8g、甘草15-20g。
一种治疗肝肾阴虚型自身免疫性肝炎的中药组合物的制备方法,包括以下步骤:
(1)按重量称取当归、何首乌、知母、川楝子、桑寄生、女贞子、远志、煅龙骨,混合,加入混合原料药物10-15倍重量的水煎煮2-3次,每次1-1.5h,过滤,合并滤液并浓缩成80℃下相对密度为1.20-1.30的浸膏A;
(2)按重量称取夏枯草、熟地黄、补骨脂、巴戟天、露蜂房、山茱萸、甘草,混合,加入混合原料药物10倍重量的石油醚,回流提取1-2h,脱脂,弃去石油醚提取液;药渣挥干石油醚,加入药渣5-15倍重量的体积浓度90%的乙醇,在70-80℃条件下回流提取2-3次,每次1-1.5h,过滤,合并滤液经减压回收乙醇至无醇味,并浓缩成60℃下相对密度为1.10-1.12的浸膏B;
(3)将浸膏A、浸膏B混合均匀,浓缩,干燥成干浸膏,粉碎,即得。
一种治疗肝肾阴虚型自身免疫性肝炎的中药组合物的制备方法,按重量称取各原料药物,混合,加入原料药物总重量5-10倍的水浸泡30min,并煎煮2-3次,每次1-1.5h,过滤,合并滤液。
中药组合物还可以制成片剂、胶囊、颗粒剂。
上述各原料药物的药理作用:
当归,味甘、辛,性温。归肝、心、脾经。补血,活血,调经止痛,润燥滑肠。主血虚诸证,月经不调,经闭,痛经,症瘕结聚,崩漏,虚寒腹痛,痿痹,肌肤麻木,肠燥便难,赤痢后重,痈疽疮疡,跌扑损伤。
何首乌,味苦、甘、涩,性微温。归肝、心、肾经。补益精血,截疟,解毒,润肠通便。用于头晕眼花,须发早白,久疟不止,痈疽瘰疬,肠燥便秘。
知母,味苦,性寒。归肺、胃、肾经。清热除烦,泻肺滋肾。用于温热病壮热烦渴,肺热咳嗽,阴虚干咳,骨蒸潮热,内热消渴。
川楝子,味苦,性寒。用小毒。归肝、胃、小肠、膀胱经。行气止痛,杀虫。用于胁肋疼痛,脘腹疼痛,疝气疼痛,虫积腹痛,头癣。
桑寄生,味苦、甘,性平。归肝,肾经。祛风湿,补肝肾,强筋骨,安胎。用于风湿痹痛,腰膝酸痛,胎漏下血,胎动不安。
女贞子,味甘、苦,性凉,归肝、肾经。补益肝肾,明目,清虚热。用于头晕目眩,须发早白,视物昏花,阴虚发热。
远志,味苦、辛,性微温。归心、肺、肾经。安神益智,祛痰开窍,消痈肿。用于惊悸失眠,多梦健忘,神昏癫痫,咳嗽痰多,痈疽肿毒。
夏枯草,味辛、苦,性寒。归肝、胆经。清肝火,散郁结,平肝阳。用于目赤肿痛,目珠夜痛,瘰疬瘿瘤,眩晕头痛。
熟地黄,味甘,性微温。归肝、肾经。养血滋阴,补精益髓。用于血虚萎黄,眩晕心悸,月经不调,潮热盗汗,消渴,腰酸耳鸣。
补骨脂,味苦、辛,性大温。归肾、脾经。补肾壮阳,固精缩尿,温脾止泻。用于肾虚阳萎,腰膝冷痛,肾虚遗精,尿频遗尿,五更泄泻。
巴戟天,味辛、甘,性微温。归肾经。补肾助阳,祛风除湿。用于阳萎尿频,宫冷不孕,风湿痹痛。
露蜂房,味微甘,性平;小毒。归肝、胃、肾经。祛风止痛,攻毒消肿,杀虫止痒。临床主风温痹痛,风虫牙痛,痈疽恶疮,瘰疬,喉舌肿痛,痔漏,风疹瘙痒,皮肤顽癣。
煅龙骨,味甘、涩,性平。归心、肝、肾经。镇静安神,平肝潜阳,收敛固涩。用于神志不安,心悸失眠,烦躁易怒,头晕目眩,虚汗,遗精,带下,崩漏。
山茱萸,味酸,性微温。归肝、肾经。补益肝肾,收敛固涩。用于头晕目眩,腰膝酸软,崩漏,带下,月经过多,遗精,遗尿,大汗不止,体虚欲脱。
甘草,味甘,性平。归心、脾、肺、胃经。补脾益气,润肺止咳,清热解毒,缓解止痛,缓和药性。
本发明配方中当归补血活血,何首乌补肝肾,益精血,熟地黄养血滋阴,女贞子补益肝肾,补骨脂补肾壮阳,五者共为君药;夏枯草清肝泻火,桑寄生补益肝肾,知母清热滋肾,远志祛痰消肿,山茱萸补益肝肾,五者共为臣药;川楝子行气止痛,露蜂房祛风止痛,煅龙骨平肝潜阳,巴戟天补肾助阳,四者共为佐药;甘草补脾益气,润肺止咳,清热解毒,缓解止痛,调和诸药,为使药。
本发明的有益效果:
本发明在中医辨证与辨病论治理论指导下,按君臣佐使原则进行遣药组方,诸药合用,以养血柔肝,滋阴补肾,散结通络为主,兼具活血化瘀、清热解毒、祛风除湿之功效,主要针对肝肾阴虚型自身免疫性肝炎,对其它证型的自身免疫性肝炎也有一定的治疗效果。
本发明为纯中药制剂,使用安全、方便,无毒副作用,不易产生耐药性,不污染环境,不引发药源性疾病,原料来源广泛,成本低廉,效果明显,能够有效治疗肝肾阴虚型自身免疫性肝炎。
具体实施方式
以下结合实施例对本发明的具体实施方式作进一步详细说明。
实施例1
一种治疗肝肾阴虚型自身免疫性肝炎的中药组合物,包括以下重量计的原料药物(一剂):当归14g、何首乌18g、知母10g、川楝子10g、桑寄生5g、女贞子18g、远志8g、夏枯草8g、熟地黄14g、补骨脂15g、巴戟天12g、露蜂房15g、煅龙骨11g、山茱萸4g、甘草15g。
其制备方法,包括以下步骤:
(1)按重量称取当归、何首乌、知母、川楝子、桑寄生、女贞子、远志、煅龙骨,混合,加入混合原料药物10倍重量的水煎煮3次,每次1h,过滤,合并滤液并浓缩成80℃下相对密度为1.20-1.30的浸膏A;
(2)按重量称取夏枯草、熟地黄、补骨脂、巴戟天、露蜂房、山茱萸、甘草,混合,加入混合原料药物10倍重量的石油醚,回流提取1h,脱脂,弃去石油醚提取液;药渣挥干石油醚,加入药渣10倍重量的体积浓度90%的乙醇,在80℃条件下回流提取2次,每次1h,过滤,合并滤液经减压回收乙醇至无醇味,并浓缩成60℃下相对密度为1.10-1.12的浸膏B;
(3)将浸膏A、浸膏B混合均匀,浓缩,干燥成干浸膏,粉碎,即得。
实施例2
一种治疗肝肾阴虚型自身免疫性肝炎的中药组合物,包括以下重量计的原料药物(一剂):当归10g、何首乌15g、知母11g、川楝子16g、桑寄生10g、女贞子15g、远志6g、夏枯草5g、熟地黄16g、补骨脂16g、巴戟天15g、露蜂房12g、煅龙骨10g、山茱萸5g、甘草20g。
其制备方法:按重量称取各原料药物,混合,加入原料药物总重量5倍的水浸泡30min,并煎煮2次,每次1h,过滤,合并滤:。
实施例3
一种治疗肝肾阴虚型自身免疫性肝炎的中药组合物,包括以下重量计的原料药物(一剂):当归16g、何首乌20g、知母12g、川楝子14g、桑寄生8g、女贞子20g、远志10g、夏枯草10g、熟地黄10g、补骨脂18g、巴戟天14g、露蜂房12g、煅龙骨12g、山茱萸8g、甘草16g。
其制备方法同实施例1。
对照例
作为对照例的中药组合物,包括以下重量计的原料药物(一剂):丹参12g、茜草10g、丹皮15g、夏枯草10g、虎杖10g、茯苓12g、大青叶8g、厚朴8g、白术12g、当归15g、红花14g、元胡6g、川芎10g、柴胡13g、肉桂7g、黄芪9g、香附13g。
其制备方法参照实施例2。
有关实验资料如下:
1、纳入标准和排除标准
纳入标准:
(1)符合自身免疫性肝炎诊断标准的患者,参照2010年美国肝病学会自身免疫性肝炎诊治指南;
(2)年龄18-65岁;
(3)未用药,或服用药物但停药2周后;
(4)获得知情同意书。
排除标准:
(1)排除合并有严重肾、脑、心内科疾病者;
(2)年龄18岁以下或65岁以上;
(3)妊娠、哺乳期妇女;
(4)因病毒性、药物性、酒精性及其他性原因导致的肝损害患者。
1.2中医辨证标准:
肝肾阴虚型:劳累尤甚,或有灼热感,头晕耳鸣,两目干涩,口燥咽干,失眠多梦,潮热或五心烦热,腰膝酸软,鼻齿衄,女子经少经闭。舌体瘦质红少津,或有裂纹,苔少,脉细数无力。
1.3治疗方案:
于2016年4月-2017年12月,符合纳入标准的肝肾阴虚型自身免疫性肝炎患者78例,男49例,女29例,随机分为试验组和对照组,每组39例。试验组分别服用实施例1的中药组合物,每日一剂,分两次服用;对照组服用对照例的中药组合物,每日一剂,分两次服用。10天为一疗程,观察服用7个疗程的情况。
1.4观察指标:
分别对患者治疗前后症状总积分、TBiL(总胆红素)、ALT(谷丙转氨酶)、ALP(碱性磷酸酶)、AST(谷草转氨酶升高)、γ-GT(γ-谷氨酰转肽酶)进行观察。
症状积分的计算方法:患者治疗前后症状积分变化,临床主要症状包括乏力、纳差、腹胀、尿黄:无症状为0分,轻度为2分,中度为4分,重度为6分。
1.5疗效评价:
痊愈:临床症状消失,肝功能恢复正常;
有效:临床症状好转,症状积分减少50%以上,肝功能指标好转,下降50%以上者;
无效:未达到以上标准视为无效。
总有效率=(痊愈例+有效例)/病例数×100%
1.6统计学方法:
应用spss软件统计分析,计量资料采用t检验,P<0.05为差异有显著性。
2、结果
2.1症状积分及肝功能:
治疗后试验组和对照组症状积分及肝功能均较治疗前改善,本发明的中药组合物在改善症状积分及肝功能上优于对照组,差异有统计学意义(P<0.05),见表1。
表1治疗前后症状积分及肝功能比较
2.2总有效率:
结果表明,本发明中药组合物的效果明显优于对照组的中药组合物,其中,本发明中药组合物试验组痊愈21例,有效16例,无效2例,总有效率94.9%,对照组痊愈14例,有效17例,无效8例,总有效率79.5%,两者比较有统计学意义(P<0.05)。
以上所述仅为本发明最佳的实施例,对于本领域的技术人员来说,本发明可以有各种更改和变化。凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。
Claims (7)
1.一种治疗肝肾阴虚型自身免疫性肝炎的中药组合物,其特征在于,包括以下重量计的原料药物:当归10-16g、何首乌15-20g、知母10-12g、川楝子10-16g、桑寄生5-10g、女贞子15-20g、远志5-10g、夏枯草5-10g、熟地黄10-16g、补骨脂15-18g、巴戟天12-15g、露蜂房12-15g、煅龙骨10-12g、山茱萸4-8g、甘草15-20g。
2.根据权利要求1所述的中药组合物,其特征在于,包括以下重量计的原料药物:当归14g、何首乌18g、知母10g、川楝子10g、桑寄生5g、女贞子18g、远志8g、夏枯草8g、熟地黄14g、补骨脂15g、巴戟天12g、露蜂房15g、煅龙骨11g、山茱萸4g、甘草15g。
3.根据权利要求1所述的中药组合物,其特征在于,包括以下重量计的原料药物:当归10g、何首乌15g、知母11g、川楝子16g、桑寄生10g、女贞子15g、远志6g、夏枯草5g、熟地黄16g、补骨脂16g、巴戟天15g、露蜂房12g、煅龙骨10g、山茱萸5g、甘草20g。
4.根据权利要求1所述的中药组合物,其特征在于,包括以下重量计的原料药物:当归16g、何首乌20g、知母12g、川楝子14g、桑寄生8g、女贞子20g、远志10g、夏枯草10g、熟地黄10g、补骨脂18g、巴戟天14g、露蜂房12g、煅龙骨12g、山茱萸8g、甘草16g。
5.一种如权利要求1-4任一项所述的中药组合物的制备方法,其特征在于,包括以下步骤:
(1)按重量称取当归、何首乌、知母、川楝子、桑寄生、女贞子、远志、煅龙骨,混合,加入混合原料药物10-15倍重量的水煎煮2-3次,每次1-1.5h,过滤,合并滤液并浓缩成80℃下相对密度为1.20-1.30的浸膏A;
(2)按重量称取夏枯草、熟地黄、补骨脂、巴戟天、露蜂房、山茱萸、甘草,混合,加入混合原料药物10倍重量的石油醚,回流提取1-2h,脱脂,弃去石油醚提取液;药渣挥干石油醚,加入药渣5-15倍重量的体积浓度90%的乙醇,在70-80℃条件下回流提取2-3次,每次1-1.5h,过滤,合并滤液经减压回收乙醇至无醇味,并浓缩成60℃下相对密度为1.10-1.12的浸膏B;
(3)将浸膏A、浸膏B混合均匀,浓缩,干燥成干浸膏,粉碎,即得。
6.一种如权利要求1-4任一项所述的中药组合物的制备方法,其特征在于,按重量称取各原料药物,混合,加入原料药物总重量5-10倍的水浸泡30min,并煎煮2-3次,每次1-1.5h,过滤,合并滤液。
7.一种如权利要求1-4任一项所述的中药组合物的制备方法,其特征在于,中药组合物还可以制成片剂、胶囊、颗粒剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810801025.XA CN108578560B (zh) | 2018-07-20 | 2018-07-20 | 一种治疗肝肾阴虚型自身免疫性肝炎的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810801025.XA CN108578560B (zh) | 2018-07-20 | 2018-07-20 | 一种治疗肝肾阴虚型自身免疫性肝炎的中药组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108578560A true CN108578560A (zh) | 2018-09-28 |
CN108578560B CN108578560B (zh) | 2021-02-05 |
Family
ID=63618661
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810801025.XA Expired - Fee Related CN108578560B (zh) | 2018-07-20 | 2018-07-20 | 一种治疗肝肾阴虚型自身免疫性肝炎的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108578560B (zh) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1686527A (zh) * | 2005-05-04 | 2005-10-26 | 殷立宁 | 一种治疗乙肝的中药 |
-
2018
- 2018-07-20 CN CN201810801025.XA patent/CN108578560B/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1686527A (zh) * | 2005-05-04 | 2005-10-26 | 殷立宁 | 一种治疗乙肝的中药 |
Non-Patent Citations (4)
Title |
---|
张晓琳,等: "自身免疫性肝炎的中医辨证论治", 《中国中医药现代远程教育》 * |
王颖,等: "中医药治疗自身免疫性肝炎的文献计量研究", 《中华中医药学刊》 * |
钱金花,等: "自身免疫性肝炎的中医辨证治疗用药特点及疗效", 《中华中医药学刊》 * |
黎胜,等: "自身免疫性肝炎中医医案诊治规律数据挖掘", 《中医杂志》 * |
Also Published As
Publication number | Publication date |
---|---|
CN108578560B (zh) | 2021-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103721045B (zh) | 用于提高肉鸡在生长过程中的免疫功能的中药免疫增强剂 | |
CN103550517A (zh) | 一种治疗肝癌的药物 | |
CN103705866A (zh) | 一种治疗月经过少的中药组合物 | |
CN104225441A (zh) | 一种治疗胃病的中药组合物及其颗粒剂和胶囊剂的制备方法 | |
CN106267120A (zh) | 一种治疗鼻炎的中药制剂及其制备方法 | |
CN104001035A (zh) | 一种治疗二型糖尿病花粉葛根中药制剂 | |
CN104958494A (zh) | 一种药物组合物在制备治疗妇科出血症药物中的用途 | |
CN101537159B (zh) | 一种中药组合物及其制备方法和应用 | |
CN104958448A (zh) | 一种治疗产褥感染的药物 | |
CN102988616B (zh) | 一种治疗贫血的中药组合物 | |
CN102988887A (zh) | 一种治疗卵巢囊肿的中药 | |
CN103611100A (zh) | 一种治疗牙疼病的中药 | |
CN103006985A (zh) | 一种治疗失眠症的中药验方 | |
CN105902888A (zh) | 一种用于治疗小儿急性肾炎的中药汤剂 | |
CN105250959A (zh) | 一种用于修复肝损伤的中药制剂及制备方法 | |
CN108578560A (zh) | 一种治疗肝肾阴虚型自身免疫性肝炎的中药组合物及其制备方法 | |
CN102228576B (zh) | 一种治疗盘状红斑狼疮的中成药 | |
CN104840891A (zh) | 一种用于酒精性心肌病的中药制剂及其制备方法 | |
CN101085281A (zh) | 治疗慢性肾炎的一种中药 | |
CN103495022A (zh) | 一种辅助治疗艾滋病的中药 | |
CN108567926B (zh) | 一种治疗瘀血阻络型自身免疫性肝炎的中药组合物及其制备方法 | |
CN103690925A (zh) | 一种治疗闭经的中药组合物 | |
CN102805795B (zh) | 一种治疗急性胸胁部软组织损伤的中药组合物及其应用 | |
CN103656199B (zh) | 一种治疗肾阴不足证型咳嗽的中药 | |
CN108671112A (zh) | 一种治疗肝郁脾虚型自身免疫性肝炎的中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210827 Address after: 450000 No. 7 Weiwu Road, Jinshui District, Zhengzhou City, Henan Province Patentee after: HENAN PROVINCIAL PEOPLE'S Hospital Patentee after: Chen Guoyong Patentee after: Wang Weiwei Address before: 450000, building 80, Mianfang West Road, Zhongyuan District, Zhengzhou City, Henan Province Patentee before: Xu Jianzhong |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20210205 |
|
CF01 | Termination of patent right due to non-payment of annual fee |